Bio Protocol is projected to rise to $0.0356 by 2027, a +6% move from its current price of $0.0307. BIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.0282 | $0.0306 | $0.0333 | -0.34% |
| May 30 | $0.0271 | $0.0305 | $0.0344 | -0.67% |
| May 31 | $0.0263 | $0.0304 | $0.0352 | -1.01% |
| Jun 1 | $0.0256 | $0.0303 | $0.0359 | -1.34% |
| Jun 2 | $0.0251 | $0.0302 | $0.0365 | -1.67% |
| Jun 3 | $0.0245 | $0.0301 | $0.037 | -2.00% |
| Jun 4 | $0.024 | $0.03 | $0.0375 | -2.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.024 | $0.03 | $0.0375 | -2.33% |
| Week 2 | $0.0214 | $0.0293 | $0.0401 | -4.60% |
| Week 3 | $0.0195 | $0.0286 | $0.0421 | -6.83% |
| Week 4 | $0.0179 | $0.028 | $0.0436 | -9.00% |
| Week 5 | $0.0166 | $0.0273 | $0.0449 | -11.12% |
| Week 6 | $0.0155 | $0.0267 | $0.046 | -13.19% |
| Week 7 | $0.0145 | $0.0261 | $0.0469 | -15.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bio Protocol is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
BIO Protocol is a token that operates in the DeSci space to enable tokenized biotech projects and IP, with holders gaining access to BIO's network of scientific communities and IP.
As of now, BIO trades at $0.0307 with a market capitalization of $65.92M and is ranked 398 by market cap. These figures place BIO among a broad universe of DeSci tokens with a relatively small but active community.
The forecast presents a year-by-year price path that starts near the current area and shows a mix of neutral and bullish years, with notable upside later in the horizon. The average forecast price moves from $0.0336 in 2026 toward higher levels by the mid-2030s and beyond, with a maximum projected price of $0.2873 in 2050 and a long-run average near $0.1249 in 2050, indicating potential long-term upside but substantial variability.
A major floor 73.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
The nearest ceiling, 97.8% above — a clean break opens room to run.
A major ceiling 139.3% above — clearing it would confirm fresh momentum.
Key BIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0342 | Sell | $0.0345 | Sell |
| MA 10 | $0.0356 | Sell | $0.0364 | Sell |
| MA 20 | $0.042 | Sell | $0.0386 | Sell |
| MA 50 | $0.0355 | Sell | $0.0363 | Sell |
| MA 100 | $0.0282 | Buy | $0.0352 | Sell |
| MA 200 | $0.0383 | Sell | $0.0438 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.50 | Neutral |
| Stoch RSI (14) | 3.77 | Buy |
| CCI (20) | -87.70 | Neutral |
| Williams %R (14) | -99.69 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -25.63 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 0.31 | Buy |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 29.71 | Buy |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.03 | Sell |
| ADX (14) | 17.15 | Neutral |
| ATR (14) | 0.00 | Info |
Near-term sentiment is BEARISH. The RSI14 is 40, suggesting modest weakness in the short term.
The price is trading relative to key moving averages, with SMA50 at $0.0355 and SMA200 at $0.0383. These indicators imply the price is hovering below both commonly watched averages, which can indicate continued pressure in the near term.
Support is at $0.028 and resistance at $0.0608. The 30-day price range spans from $0.0212 to $0.0532, highlighting the recent volatility and the near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0161 | $0.0336 | $0.0336 | 0% | Neutral | |
| $0.0256 | $0.0356 | $0.0536 | +6% | Neutral | |
| $0.0283 | $0.0417 | $0.0668 | +24% | Bullish | |
| $0.0239 | $0.0371 | $0.0623 | +11% | Neutral | |
| $0.0195 | $0.0317 | $0.0554 | -5% | Neutral | |
| $0.0298 | $0.0508 | $0.0917 | +51% | Bullish | |
| $0.0319 | $0.0566 | $0.1054 | +69% | Bullish | |
| $0.019 | $0.0352 | $0.0672 | +5% | Neutral | |
| $0.0226 | $0.0436 | $0.0854 | +30% | Bullish | |
| $0.0429 | $0.0859 | $0.1722 | +156% | Bullish | |
| $0.0204 | $0.0452 | $0.0996 | +35% | Bullish | |
| $0.0562 | $0.1249 | $0.2873 | +272% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.0161 | $0.0336 | $0.0397 | +9.21% |
| June 2026 | $0.0228 | $0.0274 | $0.0341 | -18.51% |
| July 2026 | $0.0185 | $0.0226 | $0.0289 | -17.34% |
| August 2026 | $0.0202 | $0.025 | $0.0326 | +10.63% |
| September 2026 | $0.02 | $0.025 | $0.033 | -0.05% |
| October 2026 | $0.0159 | $0.0201 | $0.0269 | -19.66% |
| November 2026 | $0.0156 | $0.0199 | $0.027 | -0.79% |
| December 2026 | $0.0175 | $0.0226 | $0.0309 | +13.20% |
Click any year to see its month-by-month BIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIO price prediction for 2026 points to an average of $0.0336 (low $0.0161, high $0.0336) — a potential gain of 0% on today's $0.0307. A consolidation phase looks the most probable path here.
In 2027, BIO is projected to trade between $0.0256 and $0.0536, averaging $0.0356 — a potential gain of +6% from today's $0.0307. That is up +6% on the projected 2026 average. Price action looks broadly range-bound.
Bio Protocol's 2028 outlook centres on $0.0417, within a $0.0283 to $0.0668 range. That is up +17% on the projected 2027 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIO could reach as high as $0.0623, with a base case around $0.0371 and support toward $0.0239 — roughly +11% from $0.0307. Price action looks broadly range-bound.
Expect BIO to range from $0.0195 to $0.0554 through 2030. The $0.0317 average target implies a -5% move from current prices. That is -14% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The BIO price prediction for 2031 points to an average of $0.0508 (low $0.0298, high $0.0917) — a potential gain of +51% on today's $0.0307. Momentum favours further upside here.
In 2032, BIO is projected to trade between $0.0319 and $0.1054, averaging $0.0566 — a potential gain of +69% from today's $0.0307. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bio Protocol's 2033 outlook centres on $0.0352, within a $0.019 to $0.0672 range. That is -38% versus the projected 2032 average. That marks a +5% change versus current levels. Price action looks broadly range-bound.
By 2034, BIO could reach as high as $0.0854, with a base case around $0.0436 and support toward $0.0226 — roughly +30% from $0.0307. Buyers look set to stay in control over this stretch.
Expect BIO to range from $0.0429 to $0.1722 through 2035. The $0.0859 average target implies a +156% move from current prices. That is up +97% on the projected 2034 average. Momentum favours further upside here.
The BIO price prediction for 2040 points to an average of $0.0452 (low $0.0204, high $0.0996) — a potential gain of +35% on today's $0.0307. Buyers look set to stay in control over this stretch.
In 2050, BIO is projected to trade between $0.0562 and $0.2873, averaging $0.1249 — a potential gain of +272% from today's $0.0307. That is up +176% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIO today (≈ 32,529.475771 BIO) could be worth
$4,063.44
+$3,063.44 (+306%) by 2050 · US Dollar
Based on the average projected BIO price of $0.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOwould be worth at today's price.
$1,000 invested in BIO on May 26, 2025 (≈ 11,394.826385 BIO) would be worth
$350.29
-$649.71 (-65.0%) today · 0.35× · US Dollar
Based on a BIO entry price of $0.087759 vs. today's $0.030741.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.038759 | $793.15 | -20.7% |
| 1 month ago | $0.030126 | $1,020.42 | +2.0% |
| 3 months ago | $0.024761 | $1,241.5 | +24.1% |
| 6 months ago | $0.061432 | $500.41 | -50.0% |
| 1 year ago | $0.087759 | $350.29 | -65.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIO forecast.
Our base-case forecast reaches $0.061 around 2035.
Implied market cap at $0.061: $130.85M
The long-range forecast shows a varied path across years, with several years labeled BULLISH and notable upside in 2031, 2032, 2035, 2040 and 2050. The decade-to-decade view includes a mix of neutral years and bullish advances that lift the average price and deliver meaningful ROIs in multiple years.
In 2026 the min/avg/max are $0.0161 / $0.0336 / $0.0336 with ROI 0 and sentiment NEUTRAL. In 2027 the min/avg/max are $0.0256 / $0.0356 / $0.0536 with ROI 6.1 and sentiment NEUTRAL. In 2028 the min/avg/max are $0.0283 / $0.0417 / $0.0668 with ROI 24.3 and sentiment BULLISH.
In 2030 the min/avg/max are $0.0195 / $0.0317 / $0.0554 with ROI -5.4 and sentiment NEUTRAL. In 2031 the min/avg/max are $0.0298 / $0.0508 / $0.0917 with ROI 51.2 and sentiment BULLISH. In 2032 the min/avg/max are $0.0319 / $0.0566 / $0.1054 with ROI 68.6 and sentiment BULLISH.
In 2035 the min/avg/max are $0.0429 / $0.0859 / $0.1722 with ROI 155.7 and sentiment BULLISH. In 2040 the min/avg/max are $0.0204 / $0.0452 / $0.0996 with ROI 34.7 and sentiment BULLISH. In 2050 the min/avg/max are $0.0562 / $0.1249 / $0.2873 with ROI 272.1 and sentiment BULLISH.
Overall, these are estimates of future price paths and should not be viewed as guarantees. The path includes volatility and a range of potential outcomes depending on market conditions and demand for DeSci tokenized biotech IP.
Tap a question to reveal the answer.
The 2026 forecast lists min $0.0161, avg $0.0336, max $0.0336 with ROI 0 and sentiment NEUTRAL.
The forecast shows a mix of neutral and bullish years, with ROI ranging from -5.4% (2030) to 272.1% (2050). Not all years are bullish, and outcomes vary.
No. The maximum forecast across years is $0.2873 (2050).
Current price is $0.0307 and market cap is $65.92M. The asset is ranked 398.
2032 forecast: min $0.0319, avg $0.0566, max $0.1054 with ROI 68.6 and sentiment BULLISH.
Bio Protocol Community Discussion
0Share your Bio Protocol price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.